ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 914,65
-0,88%
Dow Jones
38 225,66
0,85%
DAX
17 896,50
-0,14%
Brent Oil
83,815
0,22%
Bitcoin
59 585,18
0,78%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Enzo Biochem Inc (ENZ)

  7. Enzo Biochem Inc (ENZ) Actualités

ENZ Enzo Biochem Inc

1,04
0,00 (0,00%)
03 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Enzo Biochem Inc ENZ NYSE Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 1,04 00:40:23
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,05 1,03 1,06 1,04 1,04
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
13/3/202421:26GLOBEEnzo Biochem Reports Second Quarter Fiscal 2024 Results and..
28/2/202401:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:05EDGAR2Form 8-K - Current report
14/2/202416:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202415:35EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
03/2/202403:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202403:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202414:33EDGAR2Form 8-K - Current report
21/12/202322:48EDGAR2Form DEFR14A - Revised definitive proxy soliciting materials
21/12/202322:15EDGAR2Form ARS - Annual Report to Security Holders
15/12/202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/12/202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202323:16EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
03/11/202322:07EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
30/10/202322:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
30/10/202321:50EDGAR2Form 8-K - Current report
11/9/202323:14EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/9/202303:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/7/202323:19EDGAR2Form 8-K/A - Current report: [Amend]
24/7/202322:32EDGAR2Form 8-K - Current report
24/7/202322:20EDGAR2Form SC 13D/A - General statement of acquisition of..
19/7/202303:42EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
18/7/202319:19EDGAR2Form S-3/A - Registration statement under Securities Act of..
17/7/202319:38EDGAR2Form 8-K - Current report
10/7/202323:30EDGAR2Form S-3/A - Registration statement under Securities Act of..
10/7/202323:20EDGAR2Form 8-K - Current report
29/6/202323:14EDGAR2Form 11-K - Annual report of employee stock purchase,..

Dernières Valeurs Consultées

NYSE
ENZ
Enzo Biochem
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés